[NBY] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
28-Apr-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -41.65%
YoY- -818.92%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 3,255 4,610 3,124 3,643 3,826 3,045 2,629 15.28%
PBT -1,757 -2,036 -1,739 -8,206 -136 -2,155 -111 529.36%
Tax -51 -256 5 -3,488 -321 3 -2,271 -92.02%
NP -1,757 -4,032 -1,739 -8,206 -5,793 -2,155 -111 529.36%
Tax Rate - - - - - - - -
Total Cost 5,012 8,642 4,863 11,849 9,619 5,200 2,740 49.51%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -53.98 -87.46 -55.67 -225.25 -151.41 -70.77 -4.22 446.10%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.37 -1.27 -0.85 -4.33 -3.61 -1.43 -0.08 177.33%
EPS Diluted -0.37 -1.27 -0.85 -4.33 -3.61 -1.43 -0.08 177.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.